Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Correlations of jak2v617f mutation with clinical and laboratory findings in primary thrombocythemia patients].

Zhongguo shi yan xue ye xue za zhi - 1 Apr 2008

Xia Jun, Xu Wei, Zhang Su-Jiang, Sun Xue-Mei, Duan Li-Min, Li Wei-Da, Qiou Hong-Xia, Li Jian-Yong

Abstract excerpt

To evaluate the frequency of jak2v617f mutation and analyze its correlation with clinical features of primary thrombocythemia (PT) patients, the mutation was detected by allele specific polymerase chain reaction (AS-PCR), the clinical and laboratory data in 66 PT patients with and without jak2v617f mutation were compared and clinical features of these PT patients were retrospectively analyzed. The results showed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Erythropoiesis

Share to Janus Kinase 2

Share to Point Mutation

Share to Polymerase Chain Reaction

Share to Thrombocythemia, Essential

Share to Young Adult

Source

Identifiers

PMID: 18426677

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Correlations of jak2v617f mutation with clinical and laboratory findings in primary thrombocythemia patients].PMID 18426677Read ↗

[Primary thrombocythemia: diagnosis and therapy].Semantic proximity Read ↗

[JAK2V617F mutation in the patients with myeloproliferative disorder and its relation with clinical characteristics].Semantic proximity Read ↗

[Clinical features of essential thrombocythemia and primary myelofibrosis, depending on the molecular characteristics of disease].Semantic proximity Read ↗

[Correlation of JAK2V617F mutation burden with clinical features in patients with polycythemia vera and essential thrombocythemia].Semantic proximity Read ↗

[Correlative study between JAK2 mutation and thrombosis in patients with myeloproliferative neoplasm].Semantic proximity Read ↗

Impact of JAK2V617F Mutational Status on Phenotypic Features in Essential Thrombocythemia and Primary Myelofibrosis.Semantic proximity Read ↗

[Essential thrombocythemia with JAK2 V617F mutation transformed into acute myeloid leukemia without JAK2 V617F mutation:case report and literature review].Semantic proximity Read ↗

[The JAK2 mutation in myeloproliferative disorders: A predictive factor of thrombosis].Semantic proximity Read ↗

Comparison of clinicopathologic findings according to JAK2 V617F mutation in patients with essential thrombocythemia.Semantic proximity Read ↗

[Quantitative analysis for JAK2 mutation in 98 patients with essential thrombocythemia and its clinical significance].Semantic proximity Read ↗

Risk of thrombosis in patients with essential thrombocythemia and polycythemia vera according to JAK2 V617F mutation statusSemantic proximity Read ↗

[Level of Microparticles in Patients with Essential Thrombocythemia and Its Relation with JAK2V617F Mutation].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.